Literature DB >> 9098263

Vitrectomy for complications of proliferative diabetic retinopathy. Functional outcomes.

W E Smiddy1, W Feuer, W D Irvine, H W Flynn, G W Blankenship.   

Abstract

PURPOSE: To quantitate the effect of diabetic vitrectomy on each patient's visual system and function.
METHODS: The anatomic and visual acuity outcomes of diabetic vitrectomy among three surgeons at one institution over a 4-year time interval were studied. Outcome parameters describing the visual system function were defined and applied to quantitate the effect on visual system disability.
RESULTS: The anatomic and visual success rates and prognostic factors in the cohort of 213 patients by standard statistical analysis were similar to previous studies. The study eye was the eye with better vision in 68 (32%) patients at the conclusion of the study, and vision was equal to the fellow eye in 35 (16%) patients. The mean impairment of the visual system by the American Medical Association Guidelines for Disability was reduced from 61% preoperatively to 50% postoperatively. The factor associated with greatest degree of reduction of impairment of the visual system was a previtrectomy diagnosis of vitreous hemorrhage. There was at least a one-step improvement of visual system function in 65 (31%) patients.
CONCLUSIONS: Vitrectomy for complications of severe proliferative diabetic retinopathy is especially valuable in improving the patient's overall visual function.

Entities:  

Mesh:

Year:  1995        PMID: 9098263     DOI: 10.1016/s0161-6420(95)30808-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

1.  Vitrectomy for traction macular detachment in diabetic retinopathy.

Authors:  P Meier; P Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-09       Impact factor: 3.117

Review 2.  Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.

Authors:  Daisy Y Shu; Frank J Lovicu
Journal:  Prog Retin Eye Res       Date:  2017-08-12       Impact factor: 21.198

Review 3.  [Surgical treatment of diabetic retinopathy and maculopathy].

Authors:  A M Joussen; H Llacer; J Mazciewicz; B Kirchhof
Journal:  Ophthalmologe       Date:  2004-12       Impact factor: 1.059

4.  Visual and anatomical outcomes following vitrectomy for complications of diabetic retinopathy: the DRIVE UK study.

Authors:  B Gupta; S Sivaprasad; R Wong; A Laidlaw; T L Jackson; D McHugh; T H Williamson
Journal:  Eye (Lond)       Date:  2012-01-06       Impact factor: 3.775

5.  Cryotherapy of sclerotomy sites for prevention of late post-vitrectomy diabetic hemorrhage: a randomized clinical trial.

Authors:  Morteza Entezari; Alireza Ramezani; Hamid Ahmadieh; Pejman Bakhtiari; Mehdi Yaseri; Kian Soltani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-09-25       Impact factor: 3.117

6.  Long-Term Changes in Intraocular Pressure after Vitrectomy for Rhegmatogenous Retinal Detachment, Epi-Retinal Membrane, or Macular Hole.

Authors:  Kentaro Yamamoto; Takeshi Iwase; Hiroko Terasaki
Journal:  PLoS One       Date:  2016-11-29       Impact factor: 3.240

7.  Long-term outcomes of vitrectomy for proliferative diabetic retinopathy.

Authors:  Vivian Schreur; Jody Brouwers; Ramon A C Van Huet; Sandra Smeets; Milan Phan; Carel B Hoyng; Eiko K de Jong; B Jeroen Klevering
Journal:  Acta Ophthalmol       Date:  2020-07-09       Impact factor: 3.761

8.  Ultrasonic fragmentation for removing thick organized clots during diabetic vitrectomy - A novel technique.

Authors:  Deependra V Singh; Raja R Reddy; Awaneesh Upadhyay; Yog R Sharma
Journal:  Indian J Ophthalmol       Date:  2022-06       Impact factor: 2.969

Review 9.  Current management of diabetic tractional retinal detachments.

Authors:  Michael W Stewart; David J Browning; Maurice B Landers
Journal:  Indian J Ophthalmol       Date:  2018-12       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.